Dirk de Ruysscher (D.K.M.)

Ye, G., Wei, Z., Han, C., Wu, G., Wong, C., Liang, Y., Chen, X., Zhou, W., Gao, J., Liang, C., Liao, Y., Hendriks, L. E. L., Wee, L., De Ruysscher, D., Dekker, A., Zhou, H., Qi, Y., Liu, Z., & Shi, Z. (2025). AI-derived longitudinal and multi-dimensional CT classifier for non-small cell lung cancer to optimize neoadjuvant chemoimmunotherapy decision: a multicentre retrospective study. EClinicalMedicine, 89, Article 103551. https://doi.org/10.1016/j.eclinm.2025.103551

Brandão, M., Prisciandaro, E., Xenophontos, E., Mariolo, A., Sadeghi, A. H., Filippi, A. R., Levy, A., Bandura, A., Caramella, C., Dickhoff, C., de Margerie-Mellon, C., Faivre-Finn, C., Portik, D., Sanchez-Lorente, D., De Ruysscher, D., Smit, E., Gobbini, E., Fadel, E., Ruffini, E., ... Et al. (2025). Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group. Lung Cancer, 209, Article 108798. https://doi.org/10.1016/j.lungcan.2025.108798

Huijs, J. W. J., Ogliari, F. R., Damhuis, R. A. M., Jongbloed, M., Broen, M. P. G., Anten, M. H. M. E., Brandsma, D., Degens, J. H. R. J., De Ruysscher, D. K. M., & Hendriks, L. E. L. (2025). Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry. Lung Cancer, 209, Article 108806. https://doi.org/10.1016/j.lungcan.2025.108806

Puri, T., Rancati, T., Seibold, P., Webb, A., Osorio, E. V., Azria, D., Farcy-Jacquet, M.-P., Chang-Claude, J., Dunning, A., Lambrecht, M., Avuzzi, B., de Ruysscher, D., Sperk, E., Vega, A., Veldeman, L., Rosenstein, B., Kerns, S., Talbot, C., Mcwilliam, A., ... REQUITE consortium (2025). Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy. Physica Medica: European journal of medical physics, 139, Article 105178. https://doi.org/10.1016/j.ejmp.2025.105178

Ogliari, F. R., Jongbloed, M., Vaes, R. D. W., Houben, R. M. A., Bartolomeo, V., van den Borne, B. E. E. M., Degens, J., Huijs, J. W. J., Pitz, C., Steens, M., Youssef-El Soud, M., Sollini, M., De Ruysscher, D. K. M., Mitea, C., & Hendriks, L. E. L. (2025). Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. Advance online publication. https://doi.org/10.1007/s00259-025-07557-9

Huijs, J. W. J., Sadowska, A. M., Degens, J. H. R. J., Steendam, C. M. J., Bensch, F., Hijmering-Kappelle, L. B. M., de Schrevel, T. M. T., van Geffen, W. H., Youssef-El Soud, M., Steens, M. M. H., Pitz, C., De Ruysscher, D. K. M., & Hendriks, L. E. L. (2025). Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastases. Lung Cancer, 208, Article 108745. https://doi.org/10.1016/j.lungcan.2025.108745

Hattu, D., Taasti, V. T., Emans, D., Velders, M., van der Stoep, J., Vullings, A., van den Bosch, M., Buck, J., van der Salm, A., van Loon, J., Ruysscher, D. D., & Canters, R. (2025). Effects of anatomical changes on dose and normal tissue complication probabilities and the benefit of replanning in photon and proton therapy of lung cancer patients. Radiotherapy and Oncology, 211, Article 111063. https://doi.org/10.1016/j.radonc.2025.111063

Domínguez, A. S. E., Dimmers, M., Mulders, T. A., Dumoulin, D., De Ruysscher, D., Peeters, S., von der Thüsen, J., & Akram, F. (2025). Artificial intelligence for diagnosis and prognosis of thymic epithelial tumors: a systematic review. Mediastinum, 9, Article 27. https://doi.org/10.21037/med-25-34

van Aken, E. S. M., Devnani, B., Prelaj, A., Castelo-Branco, L., Marijnen, C. A. M., Martins-Branco, D., Gambacorta, M. A., Lamarca, A., Harrington, K., Minniti, G., Hecht, M., Papamichael, D., Krause, M., Cathomas, R., Lindberg, K., O'Cathail, S. M., Nestle, U., Barriuso, J., Nowicki, S., ... Gandhi, A. K. (2025). ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors. Annals of Oncology. Advance online publication. https://doi.org/10.1016/j.annonc.2025.09.008

Jongbloed, M., Bortolot, M., Willmann, J., Bartolomeo, V., Novoa, N. M., De Ruysscher, D. K. M., & Hendriks, L. E. L. (2025). Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Review. JAMA Oncology. Advance online publication. https://doi.org/10.1001/jamaoncol.2025.2891